About Shauna Whisenton

This author has not yet filled in any details.
So far Shauna Whisenton has created 3 blog entries.

FDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell Disease

On November 15, 2019, the U.S. Food and Drug Administration approved Adakveo (crizanlizumab-tmca), a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for patients age 16 years and older. “Hope has never [...]

2019-11-20T03:30:02+00:00November 20th, 2019|

NIH/Gates Foundation Collaboration to Develop Accessible, Gene-Based Cures for Sickle Cell Disease and HIV

Initial investment aims to advance accessible and scalable candidate interventions into clinical trials within 10 years. The collaboration will align aggressive, high-reward research efforts to accelerate progress on shared gene-based strategies (depicted in green) to cure sickle cell disease and HIV that are available globally including in low-resource settings, while continuing to invest in other [...]

2019-10-24T02:07:34+00:00October 24th, 2019|